Wealth Enhancement Advisory Services »

Heron Therapeutics shares owned by Wealth Enhancement Advisory Services

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Wealth Enhancement Advisory Services from 13F filings

Historical chart of Wealth Enhancement Advisory Services investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Wealth Enhancement Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Wealth Enhancement Advisory Services

Quarter filed Position value Share count Share price at filing
2024-12-31 $91k 46k 1.99
2024-06-30 $131k 37k 3.50
2024-03-31 $100k 36k 2.77
2023-12-31 $61k 36k 1.70
2023-09-30 $39k 38k 1.03

More positions owned by Wealth Enhancement Advisory Services

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares Tr Msci Intl Moment (IMTM)
Alps Etf Tr Smith Core Plus (SMTH)
Amazon (AMZN)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Schwab Strategic Tr Fundamental Intl (FNDF)
Invesco Exch Traded Fd Tr Ii Dorsey Wrgt Smlc (DWAS)
J P Morgan Exchange Traded F Us Momentum (JMOM)
Invesco Exchange Traded Fd T S&p500 Quality (SPHQ)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
American Centy Etf Tr Us Large Cap Vlu (AVLV)

View all positions for Wealth Enhancement Advisory Services

Top funds holding Heron Therapeutics

Rubric Capital Management
BlackRock
Adage Capital Partners GP
Vanguard Group
Velan Capital Investment Management
Tejara Capital
Palisade Capital Management
D. E. Shaw & Co
State Street Corporation
Point72 Asset Management
Geode Capital Management
Morgan Stanley
Congress Park Capital
JW Asset Management
Tang Capital Management

View all funds holding Heron Therapeutics